Literature DB >> 9594839

Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy.

M H Schönbeck1, H P Brunner-La Rocca, P R Vogt, M L Lachat, R Jenni, O M Hess, M I Turina.   

Abstract

BACKGROUND: Controversy exists about the choice of treatment for patients with hypertrophic obstructive cardiomyopathy. The purpose of this study was to evaluate clinical and echocardiographic long-term results in patients with hypertrophic obstructive cardiomyopathy after septal myectomy and to determine predictors of event-free survival in these patients.
METHODS: Between 1965 and 1995, 110 consecutive patients 2 to 66 years old (mean age, 37 +/- 15 years) with an invasively measured left ventricular outflow tract gradient of 86 +/- 39 mm Hg (81 +/- 42 mm Hg by Doppler echocardiography) underwent either septal myectomy only (n = 87) or myectomy combined with additional procedures (n = 23). Mean follow-up was 11.7 +/- 7.5 years. Predictors of late events were calculated using multivariate Cox regression analysis.
RESULTS: The perioperative mortality rate was 3.6% (n = 4). The cumulative survival rate at 5, 10, and 15 years was 93%, 80%, and 72%, respectively, and symptom-free survival, 77%, 50%, and 33%, respectively. Predictors of late death were New York Heart Association class III or IV (p < 0.05), congestive heart failure (p < 0.05) and additional procedures (p < 0.05). The left ventricular outflow tract gradient was nearly eliminated in all patients, the left atrial dimension decreased significantly during the early years, and left ventricular dilatation occurred late in 17 patients.
CONCLUSIONS: Septal myectomy is associated with a low perioperative mortality and a high late survival rate (72% at 15 years' follow-up). Septal myectomy is still an excellent modality in the treatment strategy for symptomatic patients with hypertrophic obstructive cardiomyopathy.

Entities:  

Mesh:

Year:  1998        PMID: 9594839     DOI: 10.1016/s0003-4975(98)00187-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  Retrograde percutaneous closure of a ventricular septal defect after myectomy for hypertrophic obstructive cardiomyopathy.

Authors:  Vikas Singh; Apurva O Badheka; Syed S Bokhari; Eduard Ghersin; Pedro Martinez Clark; William W O'Neill
Journal:  Tex Heart Inst J       Date:  2013

2.  Surgery for hypertrophic cardiomyopathy.

Authors:  James J Wu; Michael Seco; Caroline Medi; Chris Semsarian; David R Richmond; Joseph A Dearani; Hartzell V Schaff; Michael J Byrom; Paul G Bannon
Journal:  Biophys Rev       Date:  2015-01-10

3.  The efficacy of cibenzoline for reducing the left ventricular pressure gradient of hypertrophic obstructive cardiomyopathy: A case report.

Authors:  Hideki Igarashi
Journal:  J Med Ultrason (2001)       Date:  2003-06       Impact factor: 1.314

4.  Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.

Authors:  Mohammed Osman; Babikir Kheiri; Khansa Osman; Mahmoud Barbarawi; Hani Alhamoud; Fahad Alqahtani; Mohamad Alkhouli
Journal:  Clin Cardiol       Date:  2018-11-29       Impact factor: 2.882

5.  Cardiomyopathy in children.

Authors:  S C Chen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-10

6.  Late occurrence of ventricular septal rupture after deep septal myectomy for hypertrophic cardiomyopathy: Causes and management.

Authors:  Anil Kumar Singhi; Biju Govind; John Satish; Kothandam Sivakumar
Journal:  J Cardiol Cases       Date:  2021-12-30

Review 7.  Hypertrophic Cardiomyopathy-Past, Present and Future.

Authors:  Alphonsus C Liew; Vassilios S Vassiliou; Robert Cooper; Claire E Raphael
Journal:  J Clin Med       Date:  2017-12-12       Impact factor: 4.241

Review 8.  Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Angelos G Rigopoulos; Hubert Seggewiss
Journal:  Curr Cardiol Rev       Date:  2016

9.  Short atrioventricular delay pacing therapy in young and old patients with hypertrophic obstructive cardiomyopathy: good long-term results and a low need for reinterventions.

Authors:  Davood Javidgonbadi; Nils-Johan Abdon; Bert Andersson; Maria Schaufelberger; Ingegerd Östman-Smith
Journal:  Europace       Date:  2018-10-01       Impact factor: 5.214

10.  Myocardial ischemia with left ventricular outflow obstruction.

Authors:  Aron F Popov; Christian Bireta; Jan D Schmitto; Dieter Zenker; Martin Friedrich; Kasim O Coskun; Ralf Seipelt; Gerd G Hanekop; Friedrich A Schoendube
Journal:  J Cardiothorac Surg       Date:  2009-09-17       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.